US Research Institutes file patent lawsuits against Samsung for Galaxy Watch

A leading US research institute has filed a patent lawsuits against Samsung Electronics related to wearable devices including Galaxy Watch 3, Galaxy Watch 4, Galaxy Watch 5 and Watch Active 2. The lawsuits allege infringement of nine patents, which mainly includes biological parameter recognition technology of Samsung Galaxy Watch.

The reason for the patent infringement is stated as the core features of the Galaxy Watch such as heart rate, breathing rate, depth and rhtym, body temperature, activity level, skin tone and blood pressure, blood oxygen saturation measurement, and heart failure detection and monitoring technology.

Further, the technology to measure outdoor temperature, humidity, air quality and other factors is also within the scope of technical infringement alleged by the plaintiff.

As per the the information, the State University of New York Research Foundation, the University of Connecticut and Worcester Polytechnic University filed a patent lawsuit in Texas federal court on Samsung for raising the monitoring and detecting physical actions features of the smartwatch.

In June 2015, Ki Chon, a professor at the University of Connecticut, met Matthew Wiggins, senior algorithm manager at the Samsung Strategy and Innovation Center in Boston and  worked with Samsung from 2016 to 2018 on the smartwatch.

Follow our socials → Google News, Telegram, Twitter, Facebook

However, communication between the two parties ceased in 2018 and Samsung Electronics is conducting clinical trials to independently launch heart-related wearable devices.

Subsequently, Samsung received certification from the US Food and Drug Administration (FDA) in September 2020 and released a health monitoring app that can be used on the Galaxy Watch 3 and Galaxy Watch Active 2. The essence of Plaintiffs’ argument is that the smartwatch and other health monitoring apps are based on Dr. Chun’s publications and papers.